
Recurrent CDI, severe CDI, and the number of stools were linked to lower Cdiff32 scores.
Kenny Walter is an editor with HCPLive. Prior to joining MJH Life Sciences in 2019, he worked as a digital reporter covering nanotechnology, life sciences, material science and more with R&D Magazine. He graduated with a degree in journalism from Temple University in 2008 and began his career as a local reporter for a chain of weekly newspapers based on the Jersey shore. When not working, he enjoys going to the beach and enjoying the shore in the summer and watching North Carolina Tar Heel basketball in the winter.

Recurrent CDI, severe CDI, and the number of stools were linked to lower Cdiff32 scores.

Travel issues related to COVID-19 were responsible for the delay in the approval of the Biologics License Application.

Dr. Robert Califf previously ran the FDA in 2016 and 2017 under former President Barack Obama.

Executive function can include working memory, behavioral inhibition, and cognitive flexibility.

The 4 factors included baseline body mass index, fibrosis-4 index, albumin level at SVR, and alpha-foetoprotein level at SVR.

Potential donors are denied for a variety of reasons, including high body mass index, underlying chronic illnesses, or the use of antibiotics within 3 months.

There were no episode of gastrointestinal bleeding, transfusion of packed red blood cells, or octreotide infusions observed.

Dr. Carbone presented about autism management during the 2021 AAP virtual conference.

Dr. Chan said clinical practice guidelines ideally cover about 75% of patients with ADHD.

Children are now screened for autism at 18 and 24 months.

Telemedicine will likely continue to be used as a tool in autism management.

Immigrant children were less likely to be diagnosed with ADHD compared to children of US born parents.

The AAP guidelines for ADHD were first released in 2000 and last updated in 2019.

Dr. Carbone will present during AAP 2021 about managing autism in pediatric practices.

The treatment is the first FDA approved orally-administered inhibitor of the complement C5a receptor.

The most severe outcomes occurred in patients with a history of unhealthy alcohol use.

Gastrointestinal symptoms were significantly linked to severe symptoms of depression and anxiety.

Relapse occurred in 39% of the maintenance group, compared to 56% in the discontinuation group.

Serious infections occurred in less than 2% of patients treated with the medication during the duration of the 52-week trial.

Just 7% of patients in the BPA group suffered a recurrent CDI episode within 14-56 days of initiating treatment.

Taste scores were significantly correlated with depression scores for both patients with irritable bowel syndrome and functional constipation.

The ongoing PIANO registry is designed to keep real time data on the outcomes of pregnant patients with IBD.

Risky sexual behavior is the sole independent predictor of acute HDV.

Age, antibiotic use, and proton pump inhibitor use was associated with an increase in C difficile infections.

Maralixibat oral solution is indicated for the treatment of cholestatic pruritus in patients with Alagille syndrome.

Incarceration history and current opioid agonist treatment was associated with antibody testing.

Healthcare provider knowledge on fecal microbiota transplantation as a treatment for inflammatory bowel disease is still lacking.

Both proton pump inhibitors and histamine 2 receptor antagonists are commonly prescribed for stress ulcer prophylaxis in critically ill patients.

Only 1 patient died due to HCV-related complications following liver transplantation.

Dr. Diaz said patience is important in understanding the challenges patients with ADHD face during the COVID-19 pandemic.